| Bacterial isolates | Augmentine (30 µg) | Ofloxacin (5 µg) | Gentamincin (10 µg) | Nalidixic acid (30 µg) | Nitrofurantoin (300 µg) | Cotrimoxazole (25 µg) | Amoxycillin (25 µg) | Tetracycline (25 µg) |
| Clostridium clostridiforme | 0 (R) | 23 (S) | 0 (R) | 28 (S) | 0 (R) | 0 (R) | 0 (R) | 0 (R) |
| Alistipesindistinctus | 0 (R) | 0 (R) | 0 (R) | 0 (R) | 0 (R) | 0 (R) | 0 (R) | 0 (R) |
| Proteus vulgaris | 0 (R) | 0 (R) | 0 (R) | 0 (R) | 0 (R) | 0 (R) | 0 (R) | 0 (R) |
| Pseudomonas aeruginosa | 0 (R) | 31(S) | 0 (R) | 25 (S) | 15 (I) | 0 (R) | 0 (R) | 0 (R) |
| Morganellamorganic | 0 (R) | 14 (I) | 0 (R) | 16 (S) | 0 (R) | 0 (R) | 0 (R) | 0 (R) |
| Neisseria oralis | 0 (R) | 16 (S) | 0 (R) | 0 (R) | 0 (R) | 0 (R) | 0 (R) | 0 (R) |
| Legionella pneumophila | 0 (R) | 22 (S) | 0 (R) | 16 (S) | 11 (R) | 0 (R) | 0 (R) | 0 (R) |
| Vibrio fluvialis | 0 (R) | 15 (I) | 0 (R) | 0 (R) | 0 (R) | 0 (R) | 0 (R) | 0 (R) |
| Susceptibility (%) | 0 | 37.5 | 0 | 50 | 0 | 0 | 0 | 0 |
| Resistance (%) | 100 | 62.5 | 100 | 50 | 100 | 100 | 100 | 100 |